Limited benefit: Studies of bumetanide have not significantly reduced autism characteristics, but some researchers are unwilling to give up the drug. Sergey / Adobe Stock Two phase 3 clinical trials of the diuretic bumetanide were canceled by their sponsors on September 7 after preliminary data showed the drug did no better than a placebo in […]
